James Leighton-Scott is the Senior Vice President Medical for Mundipharma. James joined Napp Pharmaceuticals in 2006 as a Medical Adviser, and has since undertaken a range of leadership roles within Mundipharma’s R&D and medical organisations. These roles include transforming Mundipharma’s drug safety group into a strategic partner, building a value-focussed clinical department, and consolidating two R&D sites into a single company based in Cambridge.
A physician by training, James is passionate about developing individuals and transforming teams through authentic leadership and learning.
Press return to search